CECI, FRANCESCO
CECI, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology
2025 F. Giugliano, E. Giordano, L. Gilardi, B.T. Salimbeni, P. Zagami, A. Esposito, A. Marra, D. Trapani, P.P.M. Berton Giachetti, B. Malagutti, T. Henry, D. Deandreis, G. Curigliano, F. Ceci, C. Criscitiello
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis
2024 G. Corrao, G. Marvaso, F. Mastroleo, A. Biffi, G. Pellegrini, S. Minari, M.G. Vincini, M. Zaffaroni, D. Zerini, S. Volpe, S. Gaito, G.C. Mazzola, L. Bergamaschi, F. Cattani, G. Petralia, G. Musi, F. Ceci, O. De Cobelli, R. Orecchia, D. Alterio, B.A. Jereczek-Fossa
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models
2024 G. Marvaso, L.J. Isaksson, M. Zaffaroni, M.G. Vincini, P.E. Summers, M. Pepa, G. Corrao, G.C. Mazzola, M. Rotondi, F. Mastroleo, S. Raimondi, S. Alessi, P. Pricolo, S. Luzzago, F.A. Mistretta, M. Ferro, F. Cattani, F. Ceci, G. Musi, O. De Cobelli, M. Cremonesi, S. Gandini, D. La Torre, R. Orecchia, G. Petralia, B.A. Jereczek-Fossa
How to Report {PSMA} {PET}
2024 M. Swiha, N. Ayati, D.E. Oprea-Lager, F. Ceci, L. Emmett
A PET‐Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers
2024 S. Confalonieri, B. Matoskova, R. Pennisi, F. Martino, A. De Mario, G. Miloro, F. Montani, L. Rotta, M.E. Ferrari, L. Gilardi, F. Ceci, C.M. Grana, R. Rizzuto, C. Mammucari, P.P. Di Fiore, L. Lanzetti
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature
2023 G. Piperno, A. Ferrari, S. Volpe, F. Cattani, M. Zaffaroni, S. Comi, F. Pansini, L. Bergamaschi, G.C. Mazzola, F. Ceci, M. Colandrea, G. Petralia, R. Orecchia, B.A. Jereczek-Fossa, D. Alterio
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review
2023 F. Mattana, L. Muraglia, P. Raiwa, F. Zattoni, G. Marra, P.K.F. Chiu, I. Heidegger, V. Kasivisvanathan, C.V. Kesch, J. Olivier, F. Preisser, C. Thibault, M. Valerio, R.C.N. van den Bergh, G. Gandaglia, F. Ceci
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives
2023 L. Muraglia, F. Mattana, G. Zuccotti, F. Collamati, S. Luzzago, L.L. Travaini, G. Musi, F. Ceci
Automatic Segmentation with Deep Learning in Radiotherapy
2023 L. Isaksson, P. Summers, F. Mastroleo, G. Marvaso, G. Corrao, M. Vincini, M. Zaffaroni, F. Ceci, G. Petralia, R. Orecchia, B. Jereczek-Fossa
{PSMA} {PET}/{CT}: joint {EANM} procedure guideline/{SNMMI} procedure standard for prostate cancer imaging 2.0
2023 W.P. Fendler, M. Eiber, M. Beheshti, J. Bomanji, J. Calais, F. Ceci, S.Y. Cho, S. Fanti, F.L. Giesel, K. Goffin, U. Haberkorn, H. Jacene, P.J. Koo, K. Kopka, B.J. Krause, L. Lindenberg, C. Marcus, F.M. Mottaghy, D.E. Oprea-Lager, J.R. Osborne, M. Piert, S.P. Rowe, H. Schöder, S. Wan, H. Wester, T.A. Hope, K. Herrmann
First Live-Experience Session with PET/CT Specimen Imager: A pilot analysis in Prostate Cancer and Neuroendocrine Tumor
2023 L. Muraglia, F. Mattana, L.L. Travaini, G. Musi, E. Bertani, G. Renne, E. Pisa, M.E. Ferrari, U. Fumagalli Romario, O. De Cobelli, N. Fusco, F. Ceci
Comparison of different algorithms for the conversion of RTSS file into binary mask for SPECT-based 177Lu-peptide kidney dosimetry: impact on kidneys’ volume and absorbed dose
2023 G. Castiglione Minischetti, M.E. Ferrari, D. Alio, A. Barone, F. Ceci, C.M. Grana, F. Botta
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
2023 L. Bianchi, F. Ceci, F. Costa, E. Balestrazzi, M. Droghetti, P. Piazza, A. Pissavini, R. Mei, A. Farolfi, P. Castellucci, S. Puliatti, A. Larcher, G. Gandaglia, D. Robesti, A. Mottrie, A. Briganti, A.G. Morganti, S. Fanti, F. Montorsi, R. Schiavina, E. Brunocilla
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma]
2023 L. Lavinia Travaini, F. Botta, E. Derenzini, G. Lo Presti, M. Esmeralda Ferrari, L. Simona Air(`(o)) Farulla, T. Radice, S. Mazzara, C. Tarella, S. Pileri, S. Raimondi, F. Ceci
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
2023 S. Mazzara, L. Travaini, F. Botta, C. Granata, G. Motta, F. Melle, S. Fiori, V. Tabanelli, A. Vanazzi, S. Ramadan, T. Radice, S. Raimondi, G. Lo Presti, M.E. Ferrari, B.A. Jereczek-Fossa, C. Tarella, F. Ceci, S. Pileri, E. Derenzini
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
2022 F. Ceci, G. Rovera, G. Carlo Iorio, A. Guarneri, V. Chiofalo, R. Passera, M. Oderda, S. Dall’Armellina, V. Liberini, S. Grimaldi, M. Bello’, P. Gontero, U. Ricardi, D. Deandreis
Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy
2022 C. Zamboglou, I. Strouthos, J. Sahlmann, A. Farolfi, F. Serani, F. Medici, L. Cavallini, A.G. Morganti, C. Trapp, S.A. Koerber, J.C. Peeken, M.M.E. Vogel, K. Schiller, S.E. Combs, M. Eiber, A. Vrachimis, K. Ferentinos, S.K.B. Spohn, S. Kirste, C. Gratzke, J. Ruf, A.-. Grosu, F. Ceci, W.P. Fendler, J. Miksch, S. Kroeze, M. Guckenberger, H. Lanzafame, S. Fanti, G. Hruby, T. Wiegel, L. Emmett, N.S. Schmidt-Hegemann, C. Henkenberens
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
2022 S.K.B. Spohn, A. Farolfi, S. Schandeler, M.M.E. Vogel, J. Ruf, M. Mix, S. Kirste, F. Ceci, S. Fanti, H. Lanzafame, F. Serani, C. Gratzke, A. Sigle, S.E. Combs, D. Bernhardt, J.E. Gschwend, J.A. Buchner, C. Trapp, C. Belka, P. Bartenstein, L. Unterrainer, M. Unterrainer, M. Eiber, S.G. Nekolla, K. Schiller, A.L. Grosu, N.-. Schmidt-Hegemann, C. Zamboglou, J.C. Peeken
Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay
2022 L.S. Airo Farulla, E. Demirci, P. Castellucci, N. Alan-Selcuk, E. Fortunati, L. Gilardi, F. Ceci
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
2022 L. Gilardi, L. Simona Airò Farulla, E. Demirci, I. Clerici, E. Omodeo Salè, F. Ceci